Allergic bronchopulmonary aspergillosis revealing cystic fibrosis

Citation
B. Coltey et al., Allergic bronchopulmonary aspergillosis revealing cystic fibrosis, REV MAL RES, 18(5), 2001, pp. 549-551
Citations number
11
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
REVUE DES MALADIES RESPIRATOIRES
ISSN journal
07618425 → ACNP
Volume
18
Issue
5
Year of publication
2001
Pages
549 - 551
Database
ISI
SICI code
0761-8425(200110)18:5<549:ABARCF>2.0.ZU;2-G
Abstract
In predisposed patients, allergic bronchopulmonary aspergillosis (ABPA) can arise from aspergillus bronchial colonization. We report the case of a you ng woman who presented with a right basal pneumonia, ground glass opacities and mediastinal adenopathies on CT scan. Biological, radiological and clin ical criteria, as well as an history of childhood asthma, allowed the initi al diagnosis of ABPA. However, the unusual coexistence of an additional inf ection with Pseudomonas Aeruginosa evoked the diagnosis of cystic fibrosis, confirmed by a sweat test and genetic analysis. Under corticosteroid and a ntifungal therapy and antibiotics, the clinical and radiological evolution was favourable but immuno-allergic sensitisation persisted. The ABPA-cystic fibrosis association is not rare with an estimated prevalence of 2% to 11% according to previous studies. This variability is partly explained ky the difficulty of the diagnosis due to confounding clinical, radiological, and biological signs between ABPA and cystic fibrosis. Many predictive develop ment factors of ABPA in the context of cystic fibrosis have been reported, including respiratory function, personal or familial atopy, colonization wi th Pseudomonas Aeruginosa and age. As in non cystic fibrosis patients, the treatment requires systemic corticotherapy and itraconazole. ABPA is still often under diagnosed and should be evoked in the context of cystic fibrosi s.